Development and maturation of follicles and oocytes during the menstrual cycle are complex processes that are poorly understood. Current gonadotropin therapy for ovulation induction/IVF may result in the production of suboptimal oocytes. As we learn more about the interdependency of follicle and oocyte in natural cycles, we should enhance our ability to produce better quality oocytes in artificial cycles. This will lead to improved success in the treatment of infertility.